Skip to content

TO STUDY THE DURATION OF POSTOPERATIVE PAIN RELIEF PROVIDED BY NERVE BLOCKS IN PATIENTS UNDERGOING CESAREAN SECTION UNDER SUBARACHNOID BLOCK

A PROSPECTIVE STUDY TO EVALUATE THE ANALGESIC EFFICACY OF ULTRASOUND GUIDED TRANSVERSALIS FASCIA PLANE (TFP) BLOCK VS TRANSVERSUS ABDOMINIS PLANE (TAP) BLOCK IN CESAREAN SECTION UNDER SUBARACHNOID BLOCK - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084471
Enrollment
50
Registered
2025-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Bilateral Transversalis fascia plane block: Ultrasound guided bilateral Transversalis fascia plane block with 20ml of 0.25% Bupivacaine and 4mg Dexmethasone on each side will be given a

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing cesarean section under subarachnoid block ASA - PS ( American Society of Anesthesiologists physical status) II & III

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To assess the post operative analgesic efficacy of transversalis fascia plane (TFP) block and transverse abdominis plane (TAP) block in cesarean section under subarachnoid block (total duration of blockade , time for 1st rescue analgesic )Timepoint: Every 2nd hourly for 24hours in post-operative period

Secondary

MeasureTime frame
Post operative VAS scores at 0,2,4,6,12, 24 hours Post operative additional analgesic requirement in 24 hours. Patient satisfaction scores. Complications if any (LAST, PONV, hematoma at injection site, paresthesia, etc,.Timepoint: Every 2nd hourly for 24hours in post-operative period

Countries

India

Contacts

Public ContactDr Merin Varghese

DR.B.R AMBEDKHAR MEDICAL COLLEGE AND HOSPITAL

suvi11492@gmail.com6366279888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026